Results 111 to 120 of about 11,672,769 (309)

Network divergence analysis identifies adaptive gene modules and two orthogonal vulnerability axes in pancreatic cancer

Molecular Oncology, EarlyView.
Tumors contain diverse cellular states whose behavior is shaped by context‐dependent gene coordination. By comparing gene–gene relationships across biological contexts, we identify adaptive transcriptional modules that reorganize into distinct vulnerability axes.
Brian Nelson, Lyanne Delgado‐Coka, Natalia Marchenko, Luisa F. Escobar‐Hoyos, Kenneth R. Shroyer, Alisa Yurovsky, Trey Ideker, Gábor Balázsi, Thomas MacCarthy, Scott Powers   +9 more
wiley   +1 more source

Special Libraries, February 1946 [PDF]

, 1946
Volume 37, Issue 2https://scholarworks.sjsu.edu/sla_sl_1946/1001/thumbnail ...
Special Libraries Association
core   +1 more source

COMP–PMEPA1 axis promotes epithelial‐to‐mesenchymal transition in breast cancer cells

Molecular Oncology, EarlyView.
This study reveals that cartilage oligomeric matrix protein (COMP) promotes epithelial‐to‐mesenchymal transition (EMT) in breast cancer. We identify PMEPA1 (protein TMEPAI) as a novel COMP‐binding partner that mediates EMT via binding to the TSP domains of COMP, establishing the COMP–PMEPA1 axis as a key EMT driver in breast cancer.
Konstantinos S. Papadakos, Gilar Gorji‐bahri, Lejla Gradjan, Julia Zajac, Kacper Gil, Yvonne Thokozile Nduku, Anna M. Blom   +6 more
wiley   +1 more source

IMPDH inhibition enhances cytarabine efficacy in SAMHD1‐expressing leukaemia cells via guanine nucleotide depletion

Molecular Oncology, EarlyView.
Cytarabine is a key therapy for acute myeloid leukaemia (AML), but its efficacy is limited by the dNTPase SAMHD1, which hydrolyses its active metabolite. Screening nucleotide biosynthesis inhibitors revealed that IMPDH inhibitors selectively sensitise SAMHD1‐proficient AML cells to cytarabine.
Miriam Yagüe‐Capilla, Christopher Dirks, Caroline Eiden, Sonja K. Fesenmayer, Femke M. Hormann, Yolande Klootsema, Ingrid Lilienthal, Si Min Zhang, Nikolas Herold, Sean G. Rudd   +9 more
wiley   +1 more source

SPECIAL TREATMENT JOURNAL, 2024. Vol. 10.(SI)

Különleges Bánásmód
Journal of Special Treatment, 2024.
Editoral Board of Special Treatment Journal
doaj   +1 more source

Information Outlook, April 1997 [PDF]

, 1997
Volume 1, Issue 4https://scholarworks.sjsu.edu/sla_io_1997/1003/thumbnail ...
Special Libraries Association
core   +3 more sources

Keratin 19 as a prognostic marker and contributing factor of metastasis and chemoresistance in high‐grade serous ovarian cancer

Molecular Oncology, EarlyView.
Keratin 19 (KRT19) is overexpressed in high‐grade serous ovarian cancer with high levels of Kallikrein‐related peptidases (KLK) 4–7 and is associated with poor survival. In vivo analyses demonstrate that elevated KRT19 increases peritoneal tumour burden.
Sophia Bielesch, Isabel Vogel, Sina Nokodian, Johanna Moeller, Antonia Blechschmidt, Vicky Hecht, Vanessa Kuentzel, Katharina Thiedig, Melissa Schwab, Oliver Schilling, Holger Bronger, Marion Kiechle, Viktor Magdolen, Tobias Dreyer   +13 more
wiley   +1 more source

Special Treatment, 2025.11.(SI)

Különleges Bánásmód
Journal of Special Treatment, 2025.11.(SI) - full ...
Editorial office of Special Treatment Journal
doaj   +1 more source

Special Relativity

, 2008
Abstract This chapter begins with a discussion of Newton's mechanics. It then covers Maxwell's equations, Minkowski spacetime, Poincaré group, Lorentz group, special relativity, Newtonian law, relativistic law, equivalence of mass and energy, and continuous matter.
openaire   +1 more source

Information Outlook, August 2006 [PDF]

, 2006
Volume 10, Issue 8https://scholarworks.sjsu.edu/sla_io_2006/1007/thumbnail ...
Special Libraries Association
core   +1 more source